Fed’s Miran lays out path to shrink central bank balance sheet further

Miran said reducing market demand for liquidity could allow the Fed to shrink its ~$6.7 trillion balance sheet by roughly $1–2 trillion over time. He outlined options — easing liquidity regulations, tweaking stress tests, destigmatizing use of standing repo and the discount window, more active market-liquidity interventions, and relying on passive runoff rather than active sales — and cautioned the process would take several years and should be slow. He noted balance-sheet reduction is contractionary but can be offset by lower federal funds rates if not at the effective lower bound, and flagged that the Fed has recently halted QT and is buying T-bills to rebuild market liquidity.

Analysis

If the Fed can materially reduce the market’s demand for excess reserves without active securities sales, the private sector will gradually absorb a larger stock of Treasuries and agency paper. That reintroduction of supply is likely to lift term premia by a discrete amount over quarters-to-years (we model a central case of +25–75bp), creating a persistent headwind for long-duration assets while leaving room for policy-rate easing in a later cycle.

Easing the stigma around Fed liquidity backstops and loosening operational frictions in stress tests will lower the probability of acute funding squeezes. For banks this is a two-edged sword: it should quietly lift deployable capital and NIMs (we estimate a plausible +10–30bp NIM tailwind for active lenders) but also encourage risk‑taking that lengthens the credit cycle and raises cyclical credit risk downstream.

Near-term market technicals will dominate. Passive, slow shrinkage reduces the chance of a one-off shock, yet the path dependence means episodic volatility in repo and bill yields whenever the Fed’s purchases taper; those episodes will be the best windows to trade curve steepeners or payer swaptions. MBS and convexity-sensitive paper will experience the largest P/L swings if the market price of duration reprices faster than policy reacts.

For equities, the funding-era normalization is asymmetric: capex-heavy, high-ticket hardware suppliers should benefit from a lower tail-risk premium once liquidity stigma fades, while ad-revenue and discretionary marketing budgets (more interest-rate and growth sensitive) will rerate faster on any near-term uptick in short‑term funding costs. That creates a clear relative-value setup between enterprise hardware exposure and adtech/monetization plays over the next 3–12 months.

Key Decisions for Investors

• SMCI: Buy a 6–9 month call spread (buy ATM, sell ~+20% OTM) sized 1–2% portfolio max. Rationale: asymmetric upside if capex outlays for AI servers remain intact and funding tail‑risk declines; target 150–250% return on premium if SMCI outperforms by 30%+; max loss = premium paid.
• Pair trade (3–9 months): Long SMCI / Short APP, equal-dollar. Rationale: favor hardware exposure over adtech if liquidity stigma removal stabilizes funding for capex but bond-market term-premium moves compress discretionary ad budgets. Risk: macro slowdown that curtails capex would hurt both; target 20–40% relative outperformance.
• Rates hedge (3–12 months): Buy 6–12 month payer swaptions on 10y (or long 10y Treasury call options) sized to protect 1–2% portfolio downside versus a 25–75bp move higher in term premia. Rationale: protects against accelerated QT or surprise repricing in long-end yields; cost = insurance premium, acceptable as tail hedge.
• Financials (6–12 months): Add selective overweight to regional/scale lenders (e.g., KRE basket or 1–2 bank names) sized 2–3% portfolio. Rationale: easing liquidity stigma + regulatory tweaks should free up capital and modestly boost NIMs; target 20–30% upside with stop-loss at 15% to guard against a renewed credit shock.